"drug allergy groups"

As we discussed at our meeting and subsequently by email, one component of this work is the creation of a consistent structure within the drug allergy disorder hierarchy in SCT. In the creation of the data set in New Zealand I can give a few examples which may indicate if this work is a priority or even required at this stage. Opinions welcomed at this stage. In the meantime, I will post a few examples in Documentation which could be briefly discussed at the next meeting.